Cargando…
Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2
In a previous study, we found that induced expression of Heme Oxygenase-1 (HO-1) is responsible for the resistance of human osteosarcoma MG63 cells to the chemotherapeutic agent arsenic trioxide (ATO). The present study was aimed at investigating the molecular mechanisms underlying the induction of...
Autores principales: | Yue, Zhen, Zhong, Lingzhi, Mou, Yan, Wang, Xiaotong, Zhang, Haiying, Wang, Yang, Xia, Jianxin, Li, Ronggui, Wang, Zonggui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532976/ https://www.ncbi.nlm.nih.gov/pubmed/26283888 http://dx.doi.org/10.7150/ijms.12450 |
Ejemplares similares
-
Silencing SATB1 Inhibits the Malignant Phenotype and Increases Sensitivity of Human Osteosarcoma U2OS Cells to Arsenic Trioxide
por: Zhang, Haiying, et al.
Publicado: (2014) -
The Nuclear Translocation of Heme Oxygenase-1 in Human Diseases
por: Yang, Qing, et al.
Publicado: (2022) -
Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells
por: Ahmad, Iman M., et al.
Publicado: (2023) -
Heme-heme oxygenase-2 reduces the atherosclerosis by preventing inflammation
por: Wang, Zhenzhen, et al.
Publicado: (2022) -
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells
por: Tibullo, Daniele, et al.
Publicado: (2016)